Fascin promotes the invasion of pituitary adenoma through partial dependence on epithelial-mesenchymal transition
- PMID: 34097178
- DOI: 10.1007/s10735-021-09995-9
Fascin promotes the invasion of pituitary adenoma through partial dependence on epithelial-mesenchymal transition
Abstract
The aim of the present study was to investigate the role and potential regulatory mechanisms of fascin in the invasion and epithelial-to-mesenchymal transition of pituitary adenoma cells. A total of 30 specimens were assessed in the present study. The expression levels of fascin in the invasive pituitary adenoma group and non-invasive pituitary adenoma group were determined by immunochemistry. Fascin was downregulated via small interfering RNA in mouse pituitary AtT-20 cells. The proliferation, cell cycle and apoptosis of AtT-20 cells were assessed using Cell Counting Kit‑8 and flow cytometry. The invasion of AtT-20 cells was detected using a Transwell assay. Transmission electron microscopy was utilized to observe the ultrastructure of AtT-20 cells. Real-time quantitative PCR, Western blotting and immunofluorescence staining were utilized to detect the expression levels of fascin and EMT markers. In the present study, fascin expression and clinical characteristics were not significantly correlated in pituitary adenoma. The protein expression level of fascin in invasive pituitary adenoma was higher than that in non-invasive pituitary adenoma, as assessed by immunochemistry. Downregulation of fascin resulted in significant decreases in cell viability, proliferation and invasion, arrested the cell cycle at the G1 phase and increased apoptosis. In addition, downregulation of fascin significantly decreased the expression levels of N-cadherin, the mesenchymal cell marker vimentin and the transcription factor Twist but significantly increased the expression levels of the epithelial cell marker E-cadherin. Further experiments revealed that overexpression of E-cadherin resulted in significant decreases in cell viability, proliferation, invasion, and the expression of fascin and transcription factor Twist and also arrested the cell cycle at the G2 phase. The results of the present study suggest that suppressing the expression level of fascin could regulate the invasion, proliferation and apoptosis of pituitary tumour cells and alter the expression level of various EMT markers. The present study identified that fascin effectively promotes the invasion, proliferation and apoptosis of pituitary tumour cells partially via the EMT pathway.
Keywords: E-cadherin; Epithelial–mesenchymal transition; Fascin; N-cadherin; Pituitary adenoma; Vimentin.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Prognostic Biomarkers in Pituitary Tumours: A Systematic Review.touchREV Endocrinol. 2023 Nov;19(2):42-53. doi: 10.17925/EE.2023.19.2.12. Epub 2023 Aug 9. touchREV Endocrinol. 2023. PMID: 38187082 Free PMC article. Review.
-
CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial-mesenchymal transition.J Transl Med. 2019 Oct 4;17(1):336. doi: 10.1186/s12967-019-2088-8. J Transl Med. 2019. PMID: 31585531 Free PMC article.
-
Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.Tumour Biol. 2016 Jul;37(7):9979-87. doi: 10.1007/s13277-016-4896-2. Epub 2016 Jan 27. Tumour Biol. 2016. PMID: 26819207
-
LncRNA SNHG6 Induces Epithelial-Mesenchymal Transition of Pituitary Adenoma Via Suppressing MiR-944.Cancer Biother Radiopharm. 2022 May;37(4):246-255. doi: 10.1089/cbr.2020.3587. Epub 2020 Sep 16. Cancer Biother Radiopharm. 2022. PMID: 32935999 Free PMC article.
-
Fascin in migration and metastasis of breast cancer cells - A review.Adv Med Sci. 2023 Sep;68(2):290-297. doi: 10.1016/j.advms.2023.08.003. Epub 2023 Sep 2. Adv Med Sci. 2023. PMID: 37660543 Review.
Cited by
-
Prognostic Biomarkers in Pituitary Tumours: A Systematic Review.touchREV Endocrinol. 2023 Nov;19(2):42-53. doi: 10.17925/EE.2023.19.2.12. Epub 2023 Aug 9. touchREV Endocrinol. 2023. PMID: 38187082 Free PMC article. Review.
References
-
- Bi WL, Greenwald NF, Ramkissoon SH et al (2017) Clinical identification of oncogenic drivers and copy-number alterations in pituitary tumors. Endocrinology 158:2284–2291. https://doi.org/10.1210/en.2016-1967 - DOI - PubMed - PMC
-
- Chatzellis E, Alexandraki KI, Androulakis II et al (2015) Aggressive pituitary tumors. Neuroendocrinology 101:87–104. https://doi.org/10.1159/000371806 - DOI - PubMed
-
- Dai C, Zhang B, Liu X et al (2013) Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways. Int J Cancer 133:1982–1993. https://doi.org/10.1002/ijc.28199 - DOI - PubMed
-
- Dongre A, Weinberg RA (2019) New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 20:69–84. https://doi.org/10.1038/s41580-018-0080-4 - DOI - PubMed
-
- Easwaran H, Tsai HC, Baylin SB (2014) Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 54:716–727. https://doi.org/10.1016/j.molcel.2014.05.015 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous